MabCure Company Top Insiders
| MBCI Stock | USD 0.0001 0.00 0.00% |
MabCure employs about 3 people. The company is managed by 2 executives with a total tenure of roughly 7 years, averaging almost 3.0 years of service per executive, having 1.5 employees per reported executive. Assessment of MabCure's management performance can provide insight into the firm performance.
| Jehu Hand Insider Chief Director |
| Kimberly Peterson Insider Co Sec |
MabCure |
MabCure Management Team Effectiveness
The company has return on total asset (ROA) of (0.0422) % which means that it has lost $0.0422 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2515) %, meaning that it created substantial loss on money invested by shareholders. MabCure's management efficiency ratios could be used to measure how well MabCure manages its routine affairs as well as how well it operates its assets and liabilities.MabCure Workforce Comparison
MabCure is regarded fifth in number of employees category among its peers. The total workforce of Solar industry is now estimated at about 9,642. MabCure adds roughly 3.0 in number of employees claiming only tiny portion of equities listed under Solar industry.
MabCure Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. MabCure Price Series Summation is a cross summation of MabCure price series and its benchmark/peer.
MabCure Notable Stakeholders
A MabCure stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as MabCure often face trade-offs trying to please all of them. MabCure's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting MabCure's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jehu Hand | Chief Director | Profile | |
| Kimberly Peterson | Co Sec | Profile |
About MabCure Management Performance
The success or failure of an entity such as MabCure often depends on how effective the management is. MabCure management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of MabCure management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the MabCure management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. MabCure Inc. was founded in 2006 and is based in White Plains, New York. Mabcure is traded on OTC Exchange in the United States.
MabCure Workforce Analysis
Traditionally, organizations such as MabCure use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare MabCure within its industry.MabCure Manpower Efficiency
Return on MabCure Manpower
| Revenue Per Employee | 166.7K | |
| Revenue Per Executive | 250K | |
| Net Loss Per Employee | 4.1M | |
| Net Loss Per Executive | 6.1M |
Complementary Tools for MabCure Pink Sheet analysis
When running MabCure's price analysis, check to measure MabCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MabCure is operating at the current time. Most of MabCure's value examination focuses on studying past and present price action to predict the probability of MabCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MabCure's price. Additionally, you may evaluate how the addition of MabCure to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |